Why Enzalutamide 160 mg is Gaining Popularity Among Cancer Specialists in 2025

In 2025, cancer care continues to undergo a paradigm shift, with precision medicine and patient-centric therapies at the forefront. Among the numerous advancements, Enzalutamide 160 mg has emerged as one of the most talked-about prostate cancer drugs...